Sjogren's Syndrome Clinical Trials in Brest
2 recruitingBrest, France
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
Sjogren's SyndromeSjogren DiseaseSjögren
Cullinan Therapeutics Inc.36 enrolled11 locationsNCT07041099
Recruiting
Not Applicable
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
Sjogren's Syndrome
University Hospital, Brest1,000 enrolled1 locationNCT04931160